Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495440 · ClinicalTrials.gov registry record · NA

Families of Youth with Developmental Disabilities: a Theory-Based Intervention

A NA study of Communication and Family Conflict, sponsored by University of Notre Dame.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
2
Study locations

NCT03495440: Recruiting NA study of Communication and Family Conflict, sponsored by University of Notre Dame.

NCT03495440 is a NA study of Communication and Family Conflict that is actively recruiting participants, run by University of Notre Dame. The registered enrollment target is 150 participants, below the 1,417-participant average among 34 other Communication trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495440, a NA study of Communication and Family Conflict, is actively recruiting participants, sponsored by University of Notre Dame.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
2
Study locations

Study Summary

This study is designed to evaluate a preventive intervention program designed to support families (parents and typically developing adolescent siblings) that include a child with an intellectual and/or developmental disability. Participant families will be randomly assigned to either the treatment condition, in which they will receive psychoeducation and communication coaching over a four-week period, or the control condition, in which they will receive self-study materials. All subjects will participate in a pre-test assessment and three post-test assessments over the course of the year.

Primary Outcome

15-item parent self-report questionnaire measuring indices of marital satisfaction, including matters of disagreement, relationship dynamics, and happiness.

Interventions

  • BEHAVIORAL Center Sessions
  • BEHAVIORAL At-home

Study Locations (2)

Indiana

  • Wm. J. Shaw Center for Children and Families - Fort Wayne
  • Wm. J. Shaw Center for Children and Families - South Bend

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2017-08-04
Est. Completion 2024-12-31
Phase NA
University of Notre Dame

13 total trials

What NCT03495440 shows while recruiting

NCT03495440 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,417-participant average among 34 other Communication trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Communication appearing as the primary indexed condition, and to 2 interventions - of which Center Sessions is the first listed.

NCT03495440 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT03495440 about?

NCT03495440 is a clinical study titled "Families of Youth with Developmental Disabilities: a Theory-Based Intervention". This study is designed to evaluate a preventive intervention program designed to support families (parents and typically developing adolescent siblings) that include a child with an intellectual and/or developmental disability. Participant families will be randomly assigned to either the treatment c...

What is the current status of trial NCT03495440?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2017-08-04. Estimated completion is 2024-12-31.

What conditions does trial NCT03495440 study?

This clinical trial studies the following conditions: Communication, Family Conflict, Marital Conflict.

What interventions are being tested in trial NCT03495440?

The interventions under investigation include: Center Sessions (BEHAVIORAL), At-home (BEHAVIORAL).

Who is sponsoring clinical trial NCT03495440?

This trial is sponsored by University of Notre Dame, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03495440 being conducted?

This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03495440's enrollment target sits among peer trials

150 28th of 34 higher than 7 of 34 other Communication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03495440, the US trial registry maintained by the National Library of Medicine. NCT03495440 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.